Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer

Cancer Genetics and Cytogenetics

Volumn 92, Issue 2, 1996, Pages 130-134

  Athma, Prasanna ^a   Rappaport, Rebecca ^a   Swift, Michael ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; DNA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; INCIDENCE; MIDDLE AGED; ODDS RATIO; RECOMBINATION, GENETIC;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0030482567     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00328-7     Document Type: Article

References (26)

1. 1. Swift M (1993): Genetic aspects of ataxia-telangiectasia. Adv Neurol 61:115-235.
2. 2. Morrell D, Cromartie E, Swift M (1986): Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77:89-92.
3. 3. Swift M, Chase CL, Morrell D (1990): Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 46:21-27.
4. 4. Swift M, Sholman L, Perry M, Chase C (1976): Malignant neoplasms in the families of patients with ataxia-telangiectasia. Cancer Res 36:209-215.
5. 5. Swift M, Reitnauer PJ, Morrell D, Chase CL (1987): Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294.
6. 6. Morrell D, Chase CL, Swift M (1990): Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet 50:119-123.
7. 7. Swift M, Morrell D, Massey RB, Chase CL (1991): Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836.
8. 8. Pippard EC, Hall AJ, Barker DJ, Bridges BA (1988): Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929-32.
9. 9. Borresen A-L, Andersen TI, Tretli S., Heiberg A, Moller P (1990): Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 2:339-403.
10. 10. John Boice, quoted in Randal J (1995): ATM gene discovery may quiet carrier risk debate. J Natl Cancer Inst 87:1350-1351.
11. 11. Kasten M (1995): Ataxia-telangiectasia-Broad implications for a rare disorder. N Eng J Med 333:662-663.
12. 12. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y (1995): A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
13. 13. Collins FS (1996): BRCAl, ATM, and cancer susceptibility. Proceedings of the 87th Annual Meeting of the American Association Canadian Research 37:670.
14. 14. Gatti RA, Lange E, Rotman G, Chen X, Uhrhammer N, Liang T, Chiplunkar S, Yang L, Udar N, Dandekar S, Sheikhavandi S, Wang Z, Yang HM, Polikow J, Elashoff M, Teletar M, Sanal O, Chessa L, McConville C, Taylor M, Shiloh Y, Porras O, Borresen AL, Wegner RD, Curry C, Gerken S, Lange K, Concannon P (1994): Genetic haplotyping of ataxia-telangiectasia families localizes the major gene to an ≈850 kb region on chromosome 11q23.1. Intl J Radiat Biol 66:857-62.15.
15. 15. Swift M, Kupper LL, Chase CL (1990): Effective testing of gene-disease associations. Am J Hum Genet 47:266-274.
16. 16. Johnson DR, Levant S, Bale AE (1995): Direct molecular analysis of archival tumor tissue for loss of heterozygosity. Biotech 19:190-191.
17. 17. Lench NJ, Athma P, Ottaiano A, Sribney WM, Highsmith E, Swift M (1994): The DNA marker D11S384 shows zero recombination with the ataxia-telangiectasia locus in North American families. Intl J Rad Biol 66:S67-S69.
18. 18. Swift M, Morrell D, Cromartie E, Chamberlin R, Skolnick MH, Bishop DT (1986): The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 39:573-583.
19. 19. Szabo CI, King MC (1995): Inherited breast and ovarian cancer. Hum Molec Genet 4:1811-1817.
20. 20. Ford D, Easton DF, Peto J (1995): Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457-1462.
21. 21. New York State Cancer Registry (1990): Time Trends in Cancer Incidence, 1977-1986. State of New York, Department of Health.
22. 22. Chessa L, Lisa A, Fiorani O, Zei G (1994): Ataxia-telangiectasia in Italy: Genetic analysis. Intl J Radiat Biol 66(6 Suppl): S31-33.
23. 23. Stoppa-Lyonnet D, Aurias A (1992): Ataxia-telangiectasia: What impact in clinical oncology? Bull Cancer Paris 79:645-650.
24. 24. Byrd PJ, McConville CM, Cooper P, Parkhill J, Stankovic T, McGuire GM, Thick JA, Taylor AMR (1996): Mutations revealed by sequencing the 5′ half of the gene for ataxia-telangiectasia. Hum Mol Genet 5:145-149.
25. 25. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgenson TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NGJ, Gatti RA, Lenoir G, Lavin MF, Tatsumi K, Wegner RD, Shiloh Y, Bar-Shira A (1996): Predominance of null mutations in ataxia-telangiectasia. Hum Molec Genet 5:433-439.
26. 26. Telatar M, Wang Z, Udar N, Liang T, Bernatoskwa-Matuszkiewicz E, Lavin M, Shiloh Y, Concannon P, Good RA, Gatti RA (1996): Ataxia-telangiectasia: Mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet 59:40-44.